Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.80 |
| ▸ | NPC1 | O15118 | 6/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.75 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.70 |
| ▸ | GLA | P06280 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | CA12 | O43570 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | CA9 | Q16790 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11618998 | 0.88 | RAB9A (1.00) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL18317283 | 0.86 | CNR1 (0.76) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL30818065 | 0.86 | NPC1 (0.78) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL20379728 | 0.86 | NPC1 (0.78) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL20380104 | 0.86 | L3MBTL1 (1.00) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL20379469 | 0.86 | NPC1 (0.78) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL23747452 | 0.84 | CNR1 (0.66) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL22103790 | 0.82 | NPC1 (1.00) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL175437 | 0.82 | NPC1 (0.72) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 | |
| SCHEMBL20379320 | 0.82 | L3MBTL1 (0.74) | RAB9ANPC1KMT2AL3MBTL1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016209785-A1 | UREA GELLANTS | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-29 | — | — | WO | claimed |
| EP-3109233-A1 | UREA GELLANTS | The Procter and Gamble Company (US) | 2016-12-28 | — | — | EP | claimed |
| US-20160369208-A1 | UREA GELLANT | THE PROCTER & GAMBLE COMPANY | 2016-12-22 | — | — | US | claimed |
| US-10184096-B2 | Urea gellant | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-22 | — | — | US | disclosed |
| US-10184096-B2 | Urea gellant | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-22 | — | — | US | disclosed |
| WO-2016209785-A1 | UREA GELLANTS | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-29 | — | — | WO | disclosed |
| EP-3109233-A1 | UREA GELLANTS | The Procter and Gamble Company (US) | 2016-12-28 | — | — | EP | disclosed |
| US-20160369208-A1 | UREA GELLANT | THE PROCTER & GAMBLE COMPANY | 2016-12-22 | — | — | US | disclosed |
| US-20160369208-A1 | UREA GELLANT | THE PROCTER & GAMBLE COMPANY | 2016-12-22 | — | — | US | disclosed |
| US-20160369208-A1 | UREA GELLANT | THE PROCTER & GAMBLE COMPANY | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160369208-A1 | UREA GELLANT | UGP2, UGGT1, SLC14A1 | RAB9A 2575/4885NPC1 1374/4885KMT2A 2308/4885 |
| US-10184096-B2 | Urea gellant | UGP2, UGGT1, SLC14A1 | RAB9A 2575/4885NPC1 1374/4885KMT2A 2308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.